Related Experiment Video
Updated: May 2, 2026

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
Density-Mediated Selective Enrichment of Submicron Pathogens via Aptamer-Directed Nanoplating for Label-Free SERS
Mengwei Chen1, Hao Sun1, Zhichen Ren1
1Key Laboratory of Drug Targets and Translational Medicine for Cardio-Cerebrovascular Diseases, Medical Basic Research Innovation Center for Cardiovascular and Cerebrovascular Diseases, Ministry of Education, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Abstract:
Selective enrichment of submicron pathogens (e.g., bacteria, viruses) from complex matrices containing larger interferents remains a fundamental challenge in rapid biosensing. Conventional thermophoresis-based methods suffer from inherent size-dependent limitations and require fluorescent labeling for specificity, compromising clinical utility. Here, we propose a new strategy by exploiting density-manipulated sedimentation to break this limitation, enabling the selective enrichment of 200 nm targets from 1.3 μm interferents within 15 min. Through aptamer-directed in-situ synthesis of plasmonic nanoparticles (AgNPs) on target pathogens, we increase the apparent density of the targets, while simultaneously covering them with surface-enhanced Raman substrates. When coupled with laser-induced convection, the approach enables label-free detection of target bacteria at clinically relevant concentrations in blood serum with coexisting bacteria, as well as in clinical samples. The synergy of density-enhanced sedimentation and convection competition establishes a new microfluidic principle for particle manipulation. This work not only overcomes a critical bottleneck in point-of-care diagnostics but also provides a versatile platform for the rapid biosensing of diverse pathogens.
More Related Videos
Related Concept Videos
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Amino Acid Biosynthetic Pathways
Bioreactor Controls-III
Production of Antibiotics

